Update to Communicable Disease Control Manual, Chapter 2: Immunization, Part 4 – Biological Products & Appendix E – Management of Biologicals

Updated on: October 3, 2022

CDC

BCCDC Guidance Manual updated for COVID-19 Vaccine Eligibility includes updates such as: COVID-19 Vaccine Eligibility - Pfizer Bivalent COVID-19 vaccine has been added to the fall booster dose recommendations and is approved for those 12 years of age and older, a footnote has been added to indicate the Moderna Bivalent vaccine is the preferred product for those 12 years of age and older who are moderately to severely immunosuppressed. (Target audience: Holders of Communicable Disease Control Manuals). 

Click here to access the Immunization Manual page and supporting documents. 

Click here to access the COVID-19 vaccination toolkit for health professionals

Click here to access the Healthcare Provider Q&A

COVID-19 Vaccine Eligibility

 

Information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information.